Women have more than their fair share of healthcare needs for a variety of reasons, including:. Notes  Khera M. Go to Top. We even see new health options for women based on development of products for men! There is clearly a need for therapeutics with a more favorable risk-benefit balance.
Contact form 1
Endometriosis is estrogen-dependent and treatment typically involves suppression of the action of estrogen, with resulting effects on fertility and side effects like those of menopause. While therapeutics for female sexual dysfunction remain controversial in some circles, there were an estimated 4.
Women would welcome improved interventions from the biopharma and medical-device industries. This raises the possibility that men may someday have the option of relieving their female partners of the burden of hormonal contraception.
New therapeutics that tilt the balance in favor of treatment benefits and against risks would find a vast and increasing market as the global population ages. A study in Germany found prevalence of diagnosed endometriosis to be approximately 8.
These unmet needs also represent substantial business opportunities for developers of drugs, diagnostics and medical devices. Sex Med Rev ;— Am J Obstet Gynecol1 — Several chronic diseases disproportionately affect women, including type 2 diabetes, lupus, multiple sclerosis and depression.
There is also a need for improved diagnostics in other areas. In addition to trials of investigational products for women, Health Decisions is managing clinical trials of investigational male hormonal contraceptives. ificant unmet medical needs profoundly affect the lives of hundreds of millions of women worldwide.
Osteoporosis Therapeutics with a More Favorable Risk-Benefit Profile While there has been substantial progress in therapeutics for osteoporosis, it is not rare for women to discontinue treatment if side effects are difficult to tolerate. Prevalence of bacterial vaginosis in the United States is approximately Therefore, women need a therapeutic for bacterial vaginosis that not only cures bacterial vaginosis in the near term but also prevents recurrence.
While there has been substantial progress in therapeutics for osteoporosis, it is not rare for women to discontinue treatment if side effects are difficult to tolerate. Surgical procedures include myomectomy, endometrial ablation and hysterectomy. Testosterone therapy for female sexual dysfunction.
For example, women are vocal about their displeasure with the experience of mammography and there is a need for noninvasive prenatal diagnostics for a greater range of hereditary health conditions.